Yeah this guy sounds like someone who is going to give it a fair shake:
"Dr Stephen Griffin at the University of Leeds said, "much like hydroxychloroquine before, there has been a considerable amount of off-label use of this drug," based mainly on studies of the virus in the lab, not in people.
"The danger with such off-label use is that...the use of the drug becomes driven by specific interest group or proponents of non-conventional treatments and becomes politicised," he said, adding this trial should provide a "final answer" to whether or not Ivermectin should be used to treat coronavirus."
So the "final answer" is going to come from a study structured by someone who wants it to fail.
Yeah this guy sounds like someone who is going to give it a fair shake:
"Dr Stephen Griffin at the University of Leeds said, "much like hydroxychloroquine before, there has been a considerable amount of off-label use of this drug," based mainly on studies of the virus in the lab, not in people.
"The danger with such off-label use is that...the use of the drug becomes driven by specific interest group or proponents of non-conventional treatments and becomes politicised," he said, adding this trial should provide a "final answer" to whether or not Ivermectin should be used to treat coronavirus."
So the "final answer" is going to come from a study structured by someone who wants it to fail.